|
⚲
|
| Keyboard |
| Caffo Nathan
✚
|
|
|---|---|
| CIK # | 0001816992 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001816992] | |
| 4 | [0001816992] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Candel Therapeutics Inc | |
| Caffo Nathan | |
| ALX Oncology Holdings Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Candel Therapeutics Inc CADL
Common Stock
|
2021-07-29 | Buy | 6,000 | $8.00 | 48,000 |
|
ALX Oncology Holdings Inc ALXO
Common Stock
|
2020-07-21 | Conversion | 10,529 | ||
|
ALX Oncology Holdings Inc ALXO
Series B Convertible Preferred Stock · derivative
|
2020-07-21 | Conversion | 10,529 | ||
|
ALX Oncology Holdings Inc ALXO
Employee Stock Option (right to buy) · derivative
|
2020-07-16 | Grant | 22,794 | $0.00 |